Inflammatory Myositis Clinical Trials

4 recruiting

Inflammatory Myositis Trials at a Glance

6 actively recruiting trials for inflammatory myositis are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Paris, Cleveland, and Durham. Lead sponsors running inflammatory myositis studies include Assistance Publique - Hôpitaux de Paris, Central Adelaide Local Health Network, and Fate Therapeutics.

Browse inflammatory myositis trials by phase

Treatments under study

About Inflammatory Myositis Clinical Trials

Looking for clinical trials for Inflammatory Myositis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Myositis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Myositis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 1

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Lupus Nephritis+2 more
Fate Therapeutics244 enrolled18 locationsNCT06308978
Recruiting
Phase 2Phase 3

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

Idiopathic Inflammatory Myositis (IIM)DERMATOMYOSITIS OR POLYMYOSITIS
Restem, LLC.40 enrolled2 locationsNCT07160205
Recruiting

Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank

Inflammatory MyositisIdiopathic Inflammatory MyositisDrug-induced Inflammatory Myositis
Assistance Publique - Hôpitaux de Paris4,000 enrolled2 locationsNCT05454527
Recruiting

Rare AutoImmune SElf-management Programme Development

Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more
University of the West of England360 enrolled1 locationNCT06642870
Recruiting

ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS

Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Scleroderma Meeting+3 more
University Hospital, Strasbourg, France450 enrolled1 locationNCT06593041
Recruiting

Can a pharmacist-led education and support intervention assist patients to reduce their glucocorticoid (steroid) dose and improve outcomes for patients with rheumatic diseases?

Polymalgia RheumaticaSystemic Lupus ErythematosusInflammatory Myositis+1 more
Central Adelaide Local Health Network100 enrolled2 locationsACTRN12624000817549